Read up on the latest on NMN as a dietary supplement, next steps of action from industry associations, plus calls to action for retailers and for natural products industry members.

Check out the thought-provoking posts members of the natural products industry are sharing social media!

Nammex is requesting that FDA  "address the mislabeling of dietary supplements and functional foods as 'mushroom' or containing 'mushrooms' when they contain other fungal parts, and do not contain 'mushrooms' as claimed, or fail to disclose added grain ingredients."

North American Reishi Ltd (Nammex) announced the findings from a survey commissioned by the company involving 10,000 people in the U.S. Respondents were questioned about mushroom terminology.

The Food and Drug Administration (FDA) finally responded to a citizen petition submitted on March 7, 2023, by the Natural Products Association (NPA) and Alliance for Natural Health (ANH). Get updated on the latest.

The Consumer Healthcare Products Association (CHPA) has submitted comments to the FDA in response to a Citizen Petition asking FDA to revoke the use of the colorant titanium dioxide (TiO₂) in foods, including dietary supplements.

Read up on the latest challenges and debates as the functional mushroom supplement category booms.

The Food and Drug Administration (FDA) has rejected a request by Rep. Jeff Duncan to hold a public hearing on FDA's position on NMN. FDA's stance: A public comment period would be sufficient on the matter. 

Nammex has filed a Citizen Petition with the Food and Drug Administration requesting that the agency "address the mislabeling of dietary supplements and functional foods as 'mushroom' or containing 'mushrooms' when they contain other fungal parts, and do not contain 'mushrooms' as claimed, or fail to disclose added grain ingredients."